The Latin America, Middle East and Africa Lateral Flow Assays Market is expected to witness market growth of 5.1% CAGR during the forecast period (2021-2027).
In human health, lateral flow tests are routinely performed. They have been utilized in medical diagnostics for at-home, point-of-care, and laboratory testing. Home pregnancy examinations are the most common and popular applications of lateral flow assays. Moreover, lateral flow test kits are often used to identify animal illnesses and pollution in water supplies, animal feeds, and other sources. A lateral flow assay strip is made up of many components, including a sample pad, reaction membrane, conjugate or reagent pad, and wick or waste reservoir.
The WHO African Region registered around 94 percent of infections in 2019, with an estimated 215 million illnesses. Similarly, according to WHO 2021, a projected 37.7 million individuals were suffering from HIV by the end of year 2020, with more than two-thirds (25.4 million) residing in the WHO African geography. In addition, the prevalence of STDs or STIs is gaining a high momentum in the African region, which is leading to various health problems and serious complications. When compared to other regions, Sub-Saharan Africa has the highest annual STD cases. According to the World Health Organization, 3.5 million cases of syphilis, 16 million cases of gonorrhoea, 15 million cases of chlamydial illness, and 30 million cases of trichomoniasis occur in Africa each year.
The Brazil market dominated the LAMEA Lateral Flow Assays Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $191.9 million by 2027. The Argentina market is exhibiting a CAGR of 5.7% during (2021 - 2027). Additionally, The UAE market is expected to experience a CAGR of 4.9% during (2021 - 2027).
Based on type, the market is segmented into Kits & Reagents and Lateral Flow Readers. Based on Technique, the market is segmented into Sandwich Assays, Competitive Assays, and Multiplex Detection Assays. Based on Sample Type, the market is segmented into Blood Samples, Urine Samples, Saliva Samples, and Other Samples. Based on Application, the market is segmented into Clinical Testing, Drug Development & Quality Testing, Veterinary Diagnostics, and Food Safety & Environmental Testing. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostics Laboratories, Pharmaceuticals & Biotechnology Companies, Home Care Settings, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens AG, PerkinElmer, Inc., and F. Hoffmann-La Roche Ltd.
In human health, lateral flow tests are routinely performed. They have been utilized in medical diagnostics for at-home, point-of-care, and laboratory testing. Home pregnancy examinations are the most common and popular applications of lateral flow assays. Moreover, lateral flow test kits are often used to identify animal illnesses and pollution in water supplies, animal feeds, and other sources. A lateral flow assay strip is made up of many components, including a sample pad, reaction membrane, conjugate or reagent pad, and wick or waste reservoir.
The WHO African Region registered around 94 percent of infections in 2019, with an estimated 215 million illnesses. Similarly, according to WHO 2021, a projected 37.7 million individuals were suffering from HIV by the end of year 2020, with more than two-thirds (25.4 million) residing in the WHO African geography. In addition, the prevalence of STDs or STIs is gaining a high momentum in the African region, which is leading to various health problems and serious complications. When compared to other regions, Sub-Saharan Africa has the highest annual STD cases. According to the World Health Organization, 3.5 million cases of syphilis, 16 million cases of gonorrhoea, 15 million cases of chlamydial illness, and 30 million cases of trichomoniasis occur in Africa each year.
The Brazil market dominated the LAMEA Lateral Flow Assays Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $191.9 million by 2027. The Argentina market is exhibiting a CAGR of 5.7% during (2021 - 2027). Additionally, The UAE market is expected to experience a CAGR of 4.9% during (2021 - 2027).
Based on type, the market is segmented into Kits & Reagents and Lateral Flow Readers. Based on Technique, the market is segmented into Sandwich Assays, Competitive Assays, and Multiplex Detection Assays. Based on Sample Type, the market is segmented into Blood Samples, Urine Samples, Saliva Samples, and Other Samples. Based on Application, the market is segmented into Clinical Testing, Drug Development & Quality Testing, Veterinary Diagnostics, and Food Safety & Environmental Testing. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostics Laboratories, Pharmaceuticals & Biotechnology Companies, Home Care Settings, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens AG, PerkinElmer, Inc., and F. Hoffmann-La Roche Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Kits & Reagents
- Lateral Flow Readers
By Technique
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
By Sample Type
- Blood Samples
- Urine Samples
- Saliva Samples
- Other Samples
By Application
- Clinical Testing
- Drug Development & Quality Testing
- Veterinary Diagnostics
- Food Safety & Environmental Testing
By End User
- Hospitals & Clinics
- Diagnostics Laboratories
- Pharmaceuticals & Biotechnology Companies
- Home Care Settings
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Becton, Dickinson and Company
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Quidel Corporation
- Siemens AG
- PerkinElmer, Inc.
- F. Hoffmann-La Roche Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Lateral Flow Assays Market by Type
Chapter 5. LAMEA Lateral Flow Assays Market by Technique
Chapter 6. LAMEA Lateral Flow Assays Market by Sample Type
Chapter 7. LAMEA Lateral Flow Assays Market by Application
Chapter 8. LAMEA Lateral Flow Assays Market by End User
Chapter 9. LAMEA Lateral Flow Assays Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Becton, Dickinson and Company
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Quidel Corporation
- Siemens AG
- PerkinElmer, Inc.
- F. Hoffmann-La Roche Ltd.
Methodology
LOADING...
